Aclaris Raises $50 Million to Fund Expanded Drug Trials
WAYNE, PA — Aclaris Therapeutics Inc. (Nasdaq: ACRS) raised $50 million in an October stock and warrant offering to finance an expanding pipeline of experimental treatments for inflammatory diseases, extending …
Aclaris Raises $50 Million to Fund Expanded Drug Trials Read More